Opinion: Dearth of disability-related Covid-19 data can confound response efforts
After a few days of feeling feverish, exhausted, achy, and having an intermittent sore throat,…
Author: STAT
Watch: How some cells serve as unlikely heroes to defend the brain from viral invaders
Scientists have discovered the important role of microglia cells in protecting a mouse brain’s central…
‘Obsessed with staying alive’: Inmates describe a prison’s piecemeal response to a fatal Covid-19 outbreak
Roderick Keith Dirden has been trying for months to get out of an overcrowded dormitory…
STAT Plus: Agios drug demonstrates strong response in patients with inherited blood disorder
Agios Pharmaceuticals on Friday reported positive results from the first clinical trial of its lead…
STAT Plus: New data in sickle cell show biotech companies tackling disease in novel ways
Sickle cell disease features prominently at this year’s virtual meeting of the European Hematology Association,…
One of biotech’s biggest conferences grapples with how to talk about race and identity
If you’re trying to explain systemic racism to a group of scientists and biotech professionals,…
A new embryo-like model could help scientists study the ‘black box’ of early human development
Researchers have developed the first-ever embryo-like model from human embryonic stem cells, a workaround that…
The Chan-Zuck uprising, a virtual BIO, and the struggle to treat Covid-19
Can a virtual conference feel real? Do scientists have a say in their benefactors’ business?…
STAT Plus: Another domino falls: MIT ends negotiations with Elsevier over research access dispute
The Massachusetts Institute of Technology has ended negotiations over a new contract with the major…
STAT Plus: Pharmalittle: Pfizer CEO says Covid-19 vaccine price won’t be huge; Lilly antibody therapy may be ready by fall
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
STAT Plus: Verve, raising another $63 million, seeks to advance gene-editing treatment for heart disease
Verve Therapeutics, a Cambridge biotech that wants to use gene-editing to lower cholesterol, said Thursday…
Trump’s decision to leave WHO came with bluster, but no action so far
Nearly two weeks have passed since President Trump announced he was withdrawing the United States…
Opinion: What being stricken with Covid-19 taught a biotech CEO
On March 14, at 10 a.m., I got the call that I had tested positive…
Opinion: A pandemic, a funeral, and a chance to help heal the world
At the J.P. Morgan Healthcare Conference for biotech investors in San Francisco this January, I…
Activists, artists, and public health academics collaborate to tackle racism’s impact on heath
As it became clear that Covid-19 was disproportionately infecting and killing people of color in…
Immunity to the coronavirus remains a mystery. Scientists are trying to crack the case
Scientists stress that just because someone has recovered from Covid-19 and produced antibodies to the…
For Black youth, a time of upheaval takes a toll on mental health
From his room in Los Angeles, Cecil Hannibal worries about his grandmother getting Covid-19 every…
STAT Plus: Telehealth is a ‘silver lining’ of the pandemic, but implementing it permanently won’t be easy
The coronavirus pandemic has stretched hospital resources beyond their capacity, disrupted the delivery of care,…
STAT Plus: California supports an attorney’s unusual whistleblower lawsuit against ‘fraudulent’ patents
The California insurance commissioner is supporting an unusual gambit by a patent attorney who filed…
STAT Plus: States file a third lawsuit accusing dozens of generic drug makers of price fixing
An ongoing probe by numerous states widened with a new lawsuit accusing more than two…
STAT Plus: A patient’s microbiome could have a major impact on how drugs affect them, new research confirms
The unique array of bacteria in a person’s gut can dramatically change how well they…
STAT Plus: ‘An extremely volatile time’: New report underscores the recent rollercoaster of the biotech market
A new report from BIO shows just how chaotic the last few years have been…
23andMe says it’s ‘part of the problem’ on racial inequity. We asked geneticists what the company can do about it
At the consumer genetics giant 23andMe, CEO Anne Wojcicki last week issued a remarkable statement…
STAT Plus: Pharmalittle: Fauci encourages fair pricing for Covid-19 products; U.S. plans to start pivotal vaccine trials this summer
Good morning, everyone, and how are you today? The heat continues to rise higher here…
.jpg)
Opinion: Collective intelligence, not market competition, will deliver the best Covid-19 vaccine
Imagine mobilizing the world’s brightest and most creative minds — from biotech and pharmaceutical industries,…
The novel coronavirus attacks the lungs. A biotech company sees a common enzyme as key to protecting them
When a person is infected with the novel coronavirus, the deadliest symptoms often show up…
Can location data capture how well the Covid-19 response is working? A joint effort aims to find out
In response to the Covid-19 pandemic, tech giants have chipped in on a panoply of…
‘Flying blind’: Doctors race to understand what Covid-19 means for people with HIV
Larry Pike has already survived one pandemic. The 76-year-old Seattle retiree has been living with…
STAT Plus: Medical device startup raises almost $44M to advance a less-invasive treatment for fluid in the brain
A Massachusetts medical device startup said Tuesday it has raised $43.9 million in venture capital…
STAT Plus: Many Canadian medical societies fail to disclose industry funding in their clinical guidelines
Many Canadian medical societies and specially focused disease groups fail to disclose industry funding in…
‘I cant imagine going back’: Medicare leader calls for expanded telehealth access after Covid-19
President Trump’s top Medicare official said Tuesday that expanded access to telemedicine should continue after…
STAT Plus: A judge rules AbbVie isn’t ‘immunized’ from antitrust claims over its Humira patent dealings
In a victory for AbbVie (ABBV), a U.S. federal judge ruled the drug maker did…
STAT Plus: STAT+ Conversations
Opportunities to engage with STAT reporters and leading industry experts Join the conversation! We’re broadcasting…
STAT Plus: Judge rules AbbVie didn’t unfairly thwart Humira competition with its ‘patent thicket’
In a victory for AbbVie (ABBV), a U.S. federal judge ruled the drug maker did…
STAT Plus: As biotech drifts from amyloid hypothesis for Alzheimers, some see reason to cling on
Two biotech CEOs are cautiously optimistic about the controversial amyloid hypothesis, which suggests a sticky…
‘We don’t actually have that answer yet’: WHO clarifies comments on asymptomatic spread of Covid-19
A top World Health Organization official clarified on Tuesday that scientists have not determined yet…
Conversations with Merck’s Julie Gerberding and CMS Administrator Seema Verma
Editor’s note: The livestream will be embedded below at 12:15 p.m. ET. This month we’re…
STAT Plus: Pharmalittle: Compounders push to make pandemic changes permanent; production concerns seen for Covid-19 monoclonals
Hello, everyone, and how are you this fine, sunny morning? Here on the Pharmalot campus,…
Opinion: A national registry could help defeat sepsis, a big contributor to Covid-19 deaths
As doctors and paramedics who treat the victims of the Covid-19 pandemic, we have seen…
Opinion: To allocate remdesivir fairly, give it to communities that bear a disproportionate burden of Covid-19
As the federal government haphazardly distributed remdesivir, Gilead Sciences’ repurposed antiviral drug, to some of…
STAT Plus: The coronavirus pandemic is reigniting a fierce debate over compounded drugs
In hopes of alleviating potential drug shortages and other issues wrought by the coronavirus pandemic,…
‘The direct result of racism’: Covid-19 lays bare how discrimination drives health disparities among Black people
The disparities have long been documented. Black people are more likely than white people to…
How a family’s frantic search for remdesivir — and a 330-mile road trip — reshaped Tennessee’s Covid-19 response
This is one in a series of reports from hospitals responding to the Covid-19 pandemic. The…
Females are still routinely left out of biomedical research — and ignored in analyses of data
If you think biomedical scientists are doing a better job studying both biological sexes in…
STAT Plus: Why would AstraZeneca want to buy Gilead? Some analysts say it’s not entirely clear
Amid intense interest in Gilead Sciences (GILD) thanks to its experimental Covid-19 drug, an out-of-left-field…
STAT Plus: The next record-setting IPO: a drug company that doesn’t develop drugs
Royalty Pharma, a business built on investing in other people’s medicines, is planning to raise…
STAT Plus: Pharmalittle: Will AstraZeneca bid for Gilead?; university terminates researcher over Covid-19 papers
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Sarepta’s gene therapy for limb-girdle disease shows improved muscle function after one year
Sarepta Therapeutics said Monday that three children born with a rare muscle-wasting disease called limb-girdle…
Opinion: The Bio Revolution is changing business and society
Imagine a world in which we can produce meat without animals, cure previously incurable diseases…
After retractions of two Covid-19 papers, scientists ask what went wrong
With last week’s retractions of two Covid-19 papers from a pair of the world’s top…